当前位置: X-MOL 学术Nat. Rev. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
Nature Reviews Immunology ( IF 100.3 ) Pub Date : 2020-07-07 , DOI: 10.1038/s41577-020-0389-z
Alessandro Sette 1, 2 , Shane Crotty 1, 2
Affiliation  

T cell reactivity against SARS-CoV-2 was observed in unexposed people; however, the source and clinical relevance of the reactivity remains unknown. It is speculated that this reflects T cell memory to circulating ‘common cold’ coronaviruses. It will be important to define specificities of these T cells and assess their association with COVID-19 disease severity and vaccine responses. Recent studies have shown T cell reactivity to SARS-CoV-2 in 20–50% of unexposed individuals; it is speculated that this is due to T cell memory to common cold coronaviruses. Here, Crotty and Sette discuss the potential implications of these findings for disease severity, herd immunity and vaccine development.

中文翻译:

对 SARS-CoV-2 的预先存在的免疫力:已知和未知。

在未接触过 SARS-CoV-2 的人群中观察到 T 细胞的反应性;然而,该反应的来源和临床相关性仍然未知。据推测,这反映了 T 细胞对循环的“普通感冒”冠状病毒的记忆。定义这些 T 细胞的特异性并评估它们与 COVID-19 疾病严重程度和疫苗反应的关联非常重要。最近的研究表明,20-50% 的未暴露个体中 T 细胞对 SARS-CoV-2 具有反应性;据推测,这是由于T细胞对普通感冒冠状病毒的记忆所致。在这里,克罗蒂和塞特讨论了这些发现对疾病严重程度、群体免疫和疫苗开发的潜在影响。
更新日期:2020-07-07
down
wechat
bug